Purpose Lateral pelvic lymph node metastasis occurs in 15 to 20% of patients with locally
advanced low rectal cancer which increases risk of local recurrence and reduced survival …

Background Lateral lymph node (LLN) metastasis is a major cause of local recurrence of
advanced rectal cancer. Although there is much controversy between Western and Eastern …

The presence of lateral pelvic lymph nodes (LPLN) in advanced rectal cancer entails
challenges with ongoing debate regarding the role of prophylactic dissection vs …

Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …

BACKGROUND: Despite the use of neoadjuvant chemoradiation and total mesorectal
excision for rectal cancer, lateral pelvic lymph node recurrence is still an important problem …

Lateral pelvic lymph nodes (LPLN) are a major site for local recurrence following curative
resection for low locally advanced rectal cancer. Ongoing advances in imaging techniques …

Background Locoregional recurrence (LR) remains a problem for patients with lower rectal
cancer despite standardized surgery and improved neoadjuvant treatment regimens. Lateral …

Significant controversies exist with regards to the optimal management of lateral pelvic
lymph nodes metastases (mLLN) in patients with low rectal cancer. The differing views held …

163 Background: In the West, rectal cancer patients with pre-treatment abnormal lateral
lymph nodes (LLN) are commonly treated with neoadjuvant (chemo) radiotherapy (n (C) RT) …

Background The impact of lateral lymph node dissection (LLND) in locally advanced lower
rectal cancer remains controversial. This study is to compare total mesorectal excision (TME) …